awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33431457-A0E45CCF-53DD-4619-A5AC-C6204D12F5B2
Q33431457-A0E45CCF-53DD-4619-A5AC-C6204D12F5B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33431457-A0E45CCF-53DD-4619-A5AC-C6204D12F5B2
A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients.
P2860
Q33431457-A0E45CCF-53DD-4619-A5AC-C6204D12F5B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33431457-A0E45CCF-53DD-4619-A5AC-C6204D12F5B2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0da368d174e22d7f75c7fc1f6cf693f030e3d86a
P2860
Gemcitabine for relapsed or resistant lymphoma.